tidytlg
A tables-listings-graphs package that reached CRAN and then went quiet.
Comparison · Analytics
bundle vs DoseFinding
A side-by-side editorial comparison of bundle and DoseFinding — release velocity, themes, recent moves, and the top alternatives to consider.
bundle vs DoseFinding: at a glance
What is bundle?
Four releases in three years, each one teaching the serializer about a model type it couldn't carry
bundle solves a narrow, real problem: many R model objects hold pointers to external state — compiled boosters, Java handles, torch tensors — that do not survive being saved and reloaded in another session. It wraps them so they do. The package has shipped four releases since 2022, and the shape of each is the same: extend coverage to another model class, or repair coverage that an upstream release broke.
What is DoseFinding?
New stewardship at openpharma, then two releases adding the methods MCP-Mod was missing
DoseFinding implements MCP-Mod and related dose-response methodology for clinical trial design and analysis. In 2024 it changed hands — Marius Thomas took over as maintainer, Novartis was recorded as copyright holder and funder, and the package moved to the openpharma GitHub organisation with roxygen documentation and a proper NEWS file. The two releases since have added substantive methodology: model averaging for dose-response fitting in 1.3-1, and conditional and predictive power for interim analyses in 1.4-1.
bundle vs DoseFinding: editorial side-by-side
bundle
0.0ANALYTICS
Four releases in three years, each one teaching the serializer about a model type it couldn't carry
◆ Current state
bundle solves a narrow, real problem: many R model objects hold pointers to external state — compiled boosters, Java handles, torch tensors — that do not survive being saved and reloaded in another session. It wraps them so they do. The package has shipped four releases since 2022, and the shape of each is the same: extend coverage to another model class, or repair coverage that an upstream release broke.
◆ Where it's heading
Coverage is the product, so the release cadence is set by the ecosystem rather than by a roadmap. dbarts arrived in 0.1.2, along with extra work to preserve xgboost's nfeatures and feature_names through a round trip; 0.1.3 exists because xgboost changed its model format again. The 0.1.1 fix — recipes steps nested inside workflows — points at the same underlying issue one level up, where the object needing bundling is buried inside a tidymodels pipeline rather than passed directly.
◆ Prediction
Expect the next release to follow the same trigger: either a new parsnip engine that carries external pointers, or another upstream format change in one of the engines already covered. xgboost has now forced two of the four releases.
DoseFinding
0.0ANALYTICS
New stewardship at openpharma, then two releases adding the methods MCP-Mod was missing
◆ Current state
DoseFinding implements MCP-Mod and related dose-response methodology for clinical trial design and analysis. In 2024 it changed hands — Marius Thomas took over as maintainer, Novartis was recorded as copyright holder and funder, and the package moved to the openpharma GitHub organisation with roxygen documentation and a proper NEWS file. The two releases since have added substantive methodology: model averaging for dose-response fitting in 1.3-1, and conditional and predictive power for interim analyses in 1.4-1.
◆ Where it's heading
The pattern before the handover was maintenance — R-devel compliance, a bug fix, a link. After it, each release carries a named methodological addition with an acknowledged contributor, plus documentation to match: a longitudinal analysis vignette shipped alongside the interim power work. Housekeeping continues underneath, mostly clearing deprecated ggplot2 interfaces, aes_string in one release and qplot in the next.
◆ Prediction
Given the last two releases each added one method with a supporting vignette, expect the next to follow the same shape. Both additions so far extend the package beyond fixed dose-response fitting, so adaptive and interim methodology is the more likely direction.
Alternatives to bundle and DoseFinding
Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either bundle or DoseFinding.
Tplyr
Tplyr made clinical summary tables explain where every number came from.
rlistings
Clinical listings that keep inheriting their hardest problem — pagination — from the layer below.
hoardr
A cache-directory helper that has shipped nothing but CRAN-triggered patches for seven years.
gigs
gigs redesigned its whole conversion API for rOpenSci, then spent three releases getting the docs to build.
riem
A weather-data client that keeps rewriting its HTTP layer while slowly tightening its API.
See all bundle alternatives → · See all DoseFinding alternatives →
Recent activity from bundle and DoseFinding
Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.
- 8mo agobundlexgboost bundling updated for newer model versions
- 1y agoDoseFindingConditional and predictive power for interim analyses
- 1y agoDoseFindingModel averaging arrives for dose-response fitting ⚡
- 1y agobundledbarts BART models become bundleable
- 1y agoDoseFindingPackage moves to openpharma under new maintainership
- 2y agoDoseFindingCompliance update for R-devel
- 2y agobundleRecipes steps inside workflows now bundle correctly
- 3y agoDoseFindingpowMCTBinCount bug fix
- 3y agobundleFirst CRAN release
Frequently asked questions
What is the difference between bundle and DoseFinding?
They serve adjacent needs but don't currently overlap on shipped themes. bundle and DoseFinding are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.
Is bundle better than DoseFinding?
Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. bundle and DoseFinding are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.
What are the best alternatives to bundle?
Top bundle alternatives in Analytics are ranked by recent ship velocity. Browse the "bundle alternatives" section above for the current picks, or visit /alternatives/bundle for the full list with editorial commentary on each.
What are the best alternatives to DoseFinding?
Top DoseFinding alternatives in Analytics are ranked by recent ship velocity. Browse the "DoseFinding alternatives" section above for the current picks, or visit /alternatives/dosefinding for the full list with editorial commentary on each.